Semaglutide and liraglutide for alcohol use disorder (AUD)
GLP-1 receptor agonist medications, such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza) commonly prescribed for type 2 diabetes and obesity, may offer a promising new approach for treating Alcohol Use Disorder (AUD). Recent research from at least two large clinical trials suggests these medications significantly reduce alcohol consumption and related hospitalizations. These clinical trials support prior research that reported that weekly GLP-1 medications reduced alcohol cravings, drinking frequency, and alcohol intake.
For high consumers of alcohol, the reduction in intake with GLP-1 medications was approximately 68%, from 23.2 units to 7.8 units/week. Alcohol use in low consumers reduced from 5.5 to 2.5 units/week. Many people report the effects of GLP-1 drugs at reducing alcohol cravings was “effortless”, saying they were able to cut down their drinking without even really thinking about it.
In the US, over 28 million people aged 12 and older are diagnosed with AUD each year, including 757,000 adolescents aged 12-17 years. New treatments for AUD are needed because current AUD medications such as disulfiram, acamprosate, or naltrexone are difficult to access, underutilized, and sometimes have unpleasant side effects.
How do GLP-1 drugs reduce alcohol use?
Research indicates that GLP-1 receptors are distributed throughout brain regions involved in reward processing and addictive behaviors. When these receptors are activated, studies have observed a corresponding decrease in alcohol consumption patterns and a diminished dopamine response to alcohol.
This occurs because GLP-1 receptor stimulation appears to modify dopamine transmission within the brain's reward pathways. Multiple clinical investigations have demonstrated that individuals receiving GLP-1 medications report diminished urges to drink and consume less alcohol overall.
Scientists theorize that these effects stem from how these medications influence neural circuits controlling reward perception, satisfaction, and the feeling of fullness, potentially addressing both metabolic and addictive processes simultaneously.
Related questions
- Mounjaro vs Ozempic: Which is right for you?
- Ozempic Side Effects to Watch For
- What are the long-term side effects of Ozempic?
Latest evidence
Significant reductions in alcohol consumption were reported in 262 patients (79% female, mean age 46) treated with the GLP-1 receptor agonists, semaglutide or liraglutide for obesity, in a prospective observational study published in the journal, Diabetes, Obesity, and Metabolism.
- The average alcohol intake decreased by 7.5 units/week from 11.8 to 4.3 units/week (p<0.001).
- People who drank a lot of alcohol (more than or equal to 11 units/week) reduced intake by 68%, from 23.2 to 7.8 units/week, while low consumers reduced from 5.5 to 2.5 units/week.
- No patients reported increased alcohol consumption.
- Participants lost an average of 7.7 kg over approximately 4 months.
These findings suggest GLP-1 receptor agonists may offer dual benefits for patients with comorbid obesity and alcohol use disorder, potentially providing an integrated treatment approach.
Evidence from the Swedish Cohort Study
Semaglutide and liraglutide significantly lowered the risk of alcohol-related hospital admissions in those with AUD in a large Swedish cohort study (227,000 people) published in JAMA Psychiatry. These treatments also help reduce admissions for substance use disorder (SUD).
Patients with comorbid conditions such as type 2 diabetes or obesity, in addition to AUD, benefited the most from these treatments.
Comparative Effectiveness
Semaglutide showed the strongest results:
- 36% lower risk of AUD-related hospitalizations
- 32% lower risk of SUD-related hospitalizations
- 22% lower risk of hospitalizations for other physical conditions.
Liraglutide demonstrated the second-best results:
- 28% lower risk of AUD-related hospitalizations
- 22% lower risk of SUD-related hospitalizations
- 21% lower risk of hospitalizations for other physical conditions.
Would Mounjaro also work for AUD?
Although Mounjaro (tirzepatide) hasn't been as extensively studied as semaglutide and liraglutide for AUD, its dual-receptor mechanism might potentially offer similar or even enhanced effects on reducing alcohol consumption by influencing reward circuitry in the brain.
References
- Lähteenvuo M, Tiihonen J, Solismaa A, Tanskanen A, Mittendorfer-Rutz E, Taipale H. Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder. JAMA Psychiatry. 2025;82(1):94–98. doi:10.1001/jamapsychiatry.2024.3599
- Hendershot CS, Bremmer MP, Paladino MB, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Published online February 12, 2025. doi:10.1001/jamapsychiatry.2024.4789
- O'Farrell M, Almohaileb FI, le Roux CW. Glucagon-like peptide-1 analogues reduce alcohol intake. Diabetes Obes Metab. 2025; 27(3): 1601-1604. doi:10.1111/dom.16152
Read next
Ozempic Mounjaro Wegovy & Zepbound: Weight Loss Compared
Ozempic, Mounjaro, Wegovy and Zepbound can all lead to long-term weight loss, but only Wegovy and Zepbound are approved by the FDA for this use. In studies, Zepbound has led to a 21% weight loss in adults using the highest dose, while Wegovy has led to about a 15% weight loss.
Continue reading
Wegovy vs Ozempic: Which is Right for You?
Both Wegovy and Ozempic contain semaglutide, but Wegovy is prescribed for long-term weight management while Ozempic is used to control blood sugar levels in type 2 diabetes and help protect kidney function. They both lower the risk for heart-related complications, but they differ in other approved uses, doses, target populations and costs.
Continue reading
How long does it take for Ozempic to work?
Your blood glucose (sugar) levels should start to fully decline within the first week after you start using Ozempic (semaglutide) at your regular dose. However, the full effect can take 8 weeks or longer, as this is a long-acting medication that is injected only once per week. Continue reading
See also:
Related medical questions
- How many doses are in an Ozempic pen?
- Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
- How does Ozempic work for weight loss?
- Which GLP-1 drug is best for weight loss?
- Can you switch between Ozempic and Mounjaro?
- Does Ozempic need to be refrigerated?
- What happens when you stop taking Ozempic?
- Will my insurance cover the cost of Ozempic?
- Saxenda vs Ozempic: For Weight Loss?
- Why am I not losing weight on Ozempic?
- When is the best time of day to take Ozempic?
- Does Ozempic cause muscle loss and how to prevent it?
- Can you buy Ozempic over the counter?
- Are there natural alternatives to Ozempic for weight loss?
- Where and how should Ozempic be injected?
- Do GLP-1 drugs like Ozempic and Mounjaro cause sulfur burps?
- Rybelsus vs Ozempic for weight loss: Which to choose?
- Ozempic Face: What causes it and how to prevent it?
- How long does Ozempic last in your system?
- How long can you stay on Ozempic?
- How does Ozempic affect blood pressure?
- Is Ozempic better than metformin?
- Ozempic and Surgery: When to stop and restart?
- 6 Wegovy side effects you need to be aware of
- How long until I'll lose weight with Wegovy?
- Can you get tirzepatide from a compounding pharmacy?
- How do Zepbound and Wegovy compare?
- How do you get Wegovy covered by insurance?
- When is the best time of day to take Wegovy?
- Wegovy vs Mounjaro: Which works best for weight loss?
Drug information
- Ozempic (1,596 reviews)
- Wegovy (529 reviews)
- Semaglutide (2,778 reviews)
- Liraglutide (2,335 reviews)
Related support groups
- Ozempic (114 questions, 227 members)
- Wegovy (49 questions, 114 members)
- Semaglutide (37 questions, 53 members)
- Liraglutide (17 questions, 45 members)
- Weight Loss (Obesity/Overweight) (872 questions, 1,513 members)
- Diabetes, Type 2 (513 questions, 1,430 members)
- Cardiovascular Risk Reduction (102 questions, 28 members)
- Alcohol Dependence (47 questions, 126 members)
- Alcohol Withdrawal (31 questions, 129 members)
- Alcoholism (22 questions, 84 members)